Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Haralambos Raftopoulos"'
Autor:
Allen Lee Cohn, Howard S. Hochster, Haralambos Raftopoulos, John S. Macdonald, Susan A. Melin, Ramesh K. Ramanathan, A. Craig Lockhart, Joel Picus, Daniel J. Berg, Frank J. Brescia, Gary Frenette, Stephen A. Bernard
Publikováno v:
Cancer Chemotherapy and Pharmacology. 61:453-458
Milataxel is a novel taxane analog, with evidence of enhanced preclinical activity compared to paclitaxel and docetaxel, especially in cell lines that over express P-glycoprotein. Based on preclinical data that milataxel may be active in colorectal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f4109bc2fa2f0ae18ad6567555a5374
https://doi.org/10.1007/s00280-007-0489-5
https://doi.org/10.1007/s00280-007-0489-5
Autor:
Xiaolin Liu-Jarin, Lyall A. Gorenstein, Alain C. Borczuk, Mark B. Stoopler, Mark E. Ginsburg, Haralambos Raftopoulos
Publikováno v:
Modern Pathology. 16:1102-1108
Chemotherapy or chemoradiation is often used in Stage IIIA non-small cell lung carcinoma before surgical resection (neoadjuvant therapy). In reviewing the histopathology of such tumors after resection, the recognition that the pathologic changes are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbce414c150f7b64e775e029964fed29
https://doi.org/10.1097/01.mp.0000096041.13859.ab
https://doi.org/10.1097/01.mp.0000096041.13859.ab
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2015 (2015)
BioMed Research International, Vol 2015 (2015)
In the past two decades, significant advances have been made in the management of chemotherapy-induced nausea and vomiting (CINV). These advances are primarily due to a greater understanding of the physiological and molecular pathways underlying CINV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e10e5485711a33bc7b8954dc48385e5
https://doi.org/10.1155/2015/457326
https://doi.org/10.1155/2015/457326
Autor:
Abderrahmane Laadem, Victoria Sung, Mark J. Alexander, Matthew L. Sherman, Haralambos Raftopoulos, Madhurima Anne, Evangelos Terpos, Scott Z. Fields, Shiroo Parshad
Publikováno v:
Expert opinion on investigational drugs. 22(1)
Antagonists of activin receptor signaling may be beneficial for cancer-related anemia and bone disease caused by malignancies such as multiple myeloma and solid tumors.We review evidence of dysregulated signaling by activin receptor pathways in anemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fd1be116834ec1f571b3357cf968faf
https://pubmed.ncbi.nlm.nih.gov/23127248
https://pubmed.ncbi.nlm.nih.gov/23127248
Autor:
Gregory D.N. Pearson, Haralambos Raftopoulos, Amol Mujoomdar, Maria C. Shiau, Rohin Malhotra, John H. M. Austin, Charles A. Powell
Publikováno v:
Radiology. 242(3)
To retrospectively assess possible clinical predictors of metastatic disease to the brain in patients with non-small cell lung carcinoma (NSCLC).Institutional review board approval was obtained, informed consent was waived, and data and other informa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f2a06e8127c065b1da55d94376ed4bd
https://pubmed.ncbi.nlm.nih.gov/17229875
https://pubmed.ncbi.nlm.nih.gov/17229875
Autor:
Dennis Timony, Lawrence Glassman, Haralambos Raftopoulos, Rosemarie Buro-Cavasinni, Mohammed Aziz, Nina Kohn, Doru Paul
Publikováno v:
Journal of Clinical Oncology. 33:e19130-e19130
e19130 Background: Several studies have shown thattyrosine kinase inhibitors and chemotherapy (C)improve the short term and median survival of patients with metastatic adenocarcinoma of the lung (M...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddcfe3f434add782e6e5f18b2285218d
https://doi.org/10.1200/jco.2015.33.15_suppl.e19130
https://doi.org/10.1200/jco.2015.33.15_suppl.e19130
Autor:
Michelle Cholankeril, Todd Covey, Haralambos Raftopoulos, Reena Vora, Rachael E. Hawtin, Scott Z. Fields, Michelle Atallah, Michael Gulrajani, Alessandra Cesano, Matt Westfall
Publikováno v:
Cancer Research. 73:3523-3523
Background: SCNP is a multiparametric flow cytometry-based assay that quantitatively and simultaneously measures, at the single cell level, both extracellular surface markers and activation levels of intracellular signaling proteins in response to mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da2dfd1d99b39f5ea5525ffce523bc72
https://doi.org/10.1158/1538-7445.am2013-3523
https://doi.org/10.1158/1538-7445.am2013-3523